United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 6 minute read General business news FaverGray and Gateway Jax launch $120M N4 mixed-use project to accelerate downtown Jacksonville’s real estate revival FaverGray and Gateway Jax begin construction on N4, a $120M luxury apartment and retail hub transforming Jacksonville’s Pearl Square into a live-work destination. bySoujanya RaviJune 27, 2025